Category WTO/TRIPS

‘Final Final’ ACTA Text Published; More Discussion Ahead For EU

Negotiating partners today released the final text of the Anti-Counterfeiting Trade Agreement (ACTA) after another week of what they called “legal scrubbing” which in fitting form was once again was performed behind closed doors, this time in Sydney.

Making The Case For Responsible Science For A Safe Environment

Innovation or “jugaad” has always driven the Indian economy. However, the last decade has been witness to an emerging paradigm shift to high-quality value-added innovation, writes industry lawyer Sunita K. Sreedharan.

TRIPS Council Discusses Efficacy Of ACTA, Public Health Amendment

A substantive review of a rarely-used amendment to the World Trade Organization intellectual property rules and enforcement trends that may threaten multilateral trade system topped the agenda this week in the Council on Trade-Related Aspects of Intellectual Property Rights (TRIPS).

US Would-Be GI Wins Solidarity Award From European GI Producers

European proponents of geographical indications have granted an award to a Hawaiian coffee lacking GI protection as a sign of solidarity with the producers, they said. Europe is a prominent actor in this type of intellectual property right on products linked to a specific regions, and the French government along with a GI lobby group last week held an informational event geared towards Africa.

Big Pharma Stranglehold: Thwarting India As Independent Maker Of Blockbuster HIV Drugs?

Daniele Dionisio writes: The current break-through of multinational drug corporations in India couples with the protectionist policies pursued by the US and EU and with India’s obligations as a WTO member. Taken together, these realities mean a heavy threat to India’s freedom as independent provider of lifesaving, affordable and state-of-the-art antiretroviral medicines to the resource-limited countries.

Change Coming To Quiet UN Plant Variety Protection Agency?

Two new civil society observers were admitted last week to the Union for the Protection of New Varieties of Plants (UPOV) though whether that represents a cultural shift for the organisation or simply a procedure that has now been followed depends on who you ask. Meanwhile, a new vice secretary general prepared to take over for the first time in nearly 10 years.

Flexibility In Government Procurement Needed For Developing Countries

If public procurement for innovation is to be seen as part of developing countries’ industrial-policy portfolio, a recent paper argues accession to the GPA would not help, and advises against it, writes Riaz K. Tayob.

Emerging Economies’ New Initiative On Falsified And Substandard Medicines

Several major generic-medicine producing nations last week held a discussion on the dangers of compromised medical products and joined together to urge new steps such as defining terms, focussing on public health and strengthening national regulatory capabilities beyond strictly enforcement actions that they say have been manipulated and at times counterproductive.

Minister: India Anticipates European Fix To Law Delaying Generics Shipments

Europe has promised at the "highest levels" to fix laws that caused generic medicine seizures in the Netherlands, the Indian Minister of Commerce and Industry said today. The minister is in Geneva for meetings on the ongoing Doha Round trade liberalisation talks at the World Trade Organization.

US Attorney General In China Talks Tough, Blurs Line, On IP

United States Attorney General Eric Holder today called on other governments to join in intensifying the fight against intellectual property infringement, on the theme that, “intellectual property crimes are not victimless.” But his law enforcement argument may need finessing to reach all stakeholders.